CRVS

Corvus Pharmaceuticals, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Miller Richard A MDDirector, Officer: President And CEO
$60k5k shares
BuyMay 18, 2026
$12.05
--
Miller Richard A MDDirector, Officer: President And CEO
$23k1.9k shares
BuyMay 18, 2026
$12.01
--
Orbimed Advisors LLCDirector, 10 Percent Owner:
$4.9M1.2M shares
SellJun 27, 2025
$4.16
--
Thompson Peter A.Director, 10 Percent Owner:
$4.9M1.2M shares
SellJun 27, 2025
$4.16
--

News

globenewswire.comCorvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in Chinaglobenewswire.comJun 9globenewswire.comCorvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in Chinaglobenewswire.comJun 9seekingalpha.comCorvus Pharmaceuticals, Inc. (CRVS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 8globenewswire.comCorvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conferenceglobenewswire.comMay 20seekingalpha.comCorvus Pharmaceuticals: The Market Is Pricing Atopic Dermatitis Success Too Earlyseekingalpha.comMay 19